Views: 621 Author: Site Editor Publish Time: 2026-06-23 Origin: Site
If you've ever compared the ingredient lists of popular artificial tears, you've likely noticed two recurring names: sodium hyaluronate (SH) and carboxymethylcellulose (CMC). Both appear in leading brands—Refresh, TheraTears, Systane—yet they work through fundamentally different mechanisms.
Here's what makes the comparison interesting: clinical studies show that combining these two polymers outperforms using either alone. In a 90-day randomized trial involving 365 contact lens wearers, drops containing both CMC and hyaluronic acid significantly outperformed CMC-only drops in reducing dryness, burning sensations, and lid wiper epitheliopathy.
This finding flips the typical "which is better" comparison on its head. Rather than pitting sodium hyaluronate against carboxymethylcellulose, the evidence suggests the real opportunity lies in understanding how each polymer's unique properties can be leveraged—separately for specific applications, or combined for enhanced efficacy.
This article examines the science behind both polymers, what clinical trials reveal about their relative performance, and the emerging evidence supporting strategic combination formulations.
Sodium hyaluronate is the sodium salt of hyaluronic acid (HA)—a naturally occurring glycosaminoglycan found throughout the human body, including the aqueous humor of the eye, joint synovial fluid, and skin connective tissue.
What makes sodium hyaluronate particularly effective in eye drops:
Molecular Structure
Sodium hyaluronate consists of repeating disaccharide units of N-acetylglucosamine and glucuronic acid. Its negative charge (from carboxyl groups) allows strong water binding—each molecule can hold up to 1,000 times its weight in water.
Size Matters
As a semi-synthetic derivative with smaller molecular weight than native hyaluronic acid, sodium hyaluronate achieves better corneal penetration while retaining excellent water-retention capacity. This balance makes it particularly effective for both lubrication and hydration.
Dual Functionality
Unlike simple viscosity enhancers, sodium hyaluronate provides:
· Humectant action (water attraction and retention)
· Mucoadhesive properties (binding to ocular surface)
· Viscoelastic lubrication (shear-thinning behavior)
· Epithelial wound healing promotion
Carboxymethylcellulose (CMC), also called carmellose, is derived from natural cellulose through chemical modification—adding carboxymethyl groups makes the normally water-insoluble cellulose polymer water-soluble.
Molecular Characteristics
CMC is an anionic polysaccharide with glucopyranose subunits. Its linear chain structure provides excellent thickening capability and, crucially, direct binding to corneal epithelial cells.
Mucoadhesive Excellence
Research published in clinical ophthalmology journals demonstrates that CMC binds directly to corneal epithelial cells for several hours through interactions between its glucopyranose subunits and glucose transporters on cell surfaces. This binding:
· Creates a protective coating over the ocular surface
· Extends precorneal residence time
· Stimulates epithelial cell migration for wound healing
Formulation Advantages
For manufacturers, CMC offers practical benefits:
· Well-established safety profile with decades of use
· Cost-effective compared to hyaluronic acid derivatives
· Stable across a wide pH range
· Compatible with various preservatives and excipients
Sodium hyaluronate provides dry eye relief through several interconnected mechanisms:
Water Retention and Humectant Action
The negatively charged carboxyl and hydroxyl groups form hydrogen bonds with water molecules, creating a moisture reservoir on the ocular surface. Studies show sodium hyaluronate maintains better hydration than many alternative polymers.
Viscoelastic Lubrication
Like hyaluronic acid, sodium hyaluronate exhibits non-Newtonian (shear-thinning) behavior:
· At rest: High viscosity provides sustained corneal coverage
· During blinking: Viscosity decreases for smooth spread across the ocular surface
· After blinking: Viscosity recovers to maintain the protective film
This dynamic behavior mirrors natural tear film function more closely than simple thickeners.
CD44 Receptor Interaction
Sodium hyaluronate binds to CD44 receptors on corneal epithelial cells, triggering intracellular signaling that:
· Promotes cell migration and proliferation
· Accelerates wound healing
· Modulates inflammatory responses
· Supports endogenous hyaluronic acid production
Barrier Protection
Sodium hyaluronate forms a staggered, reticular structure on the ocular surface that delays water evaporation and protects against environmental insults.
CMC works primarily through surface coating and enhanced retention:
Direct Epithelial Binding
Unlike polymers that merely coat the surface, CMC binds directly to corneal epithelial cells through glucose transporter interactions. This molecular "docking" creates:
· Prolonged retention on the ocular surface
· Enhanced protection against mechanical friction
· Sustained release of moisture over hours
Tear Film Stabilization
CMC increases tear film viscosity and reduces tear clearance rate, stabilizing the lipid-aqueous-mucin layers that comprise natural tears.
Wound Healing Support
Research demonstrates CMC's ability to:
· Stimulate epithelial cell migration
· Accelerate re-epithelialization of corneal wounds
· Protect exposed tissue during healing
While both polymers provide lubrication and hydration, their primary mechanisms differ:
Mechanism | Sodium Hyaluronate | Carboxymethylcellulose |
Primary action | Humectant + lubricant | Mucoadhesive + coating |
Retention mechanism | Viscoelastic film | Direct epithelial binding |
Wound healing | CD44-mediated signaling | Cell migration stimulation |
Viscosity behavior | Shear-thinning | More Newtonian |
Molecular basis | Charge-based water binding | Glucose transporter binding |
This mechanistic distinction explains why clinical studies sometimes show different outcomes for specific patient populations or symptoms.
Multiple clinical trials have directly compared sodium hyaluronate and carboxymethylcellulose in treating dry eye disease.
Indian Journal of Ophthalmology Study (2023)
This randomized controlled trial enrolled 60 patients with mild to moderate dry eye disease, assigning them to receive either 0.1% sodium hyaluronate or 0.5% carboxymethylcellulose eye drops four times daily for 8 weeks.
Key findings:
· Both groups showed significant improvement in symptoms, tear film breakup time (TBUT), and Schirmer test values from baseline
· Sodium hyaluronate group showed faster improvement in Schirmer values at 4 weeks
· At 8 weeks, both groups achieved comparable objective measures
· Sodium hyaluronate showed "greater improvement" in subjective symptom scores
· No significant adverse effects in either group
Interpretation: The study concluded both polymers demonstrate "equal efficacy" in treating mild to moderate dry eye, with sodium hyaluronate potentially offering faster symptom relief and superior subjective outcomes.
A comprehensive systematic review analyzing multiple studies found:
· Results often favor neither polymer decisively in objective measures
· Sodium hyaluronate tends to show advantages in subjective symptom improvement
· Both polymers effectively improve tear film stability
· Individual patient response varies significantly
Perhaps the most clinically significant finding comes from studies examining combined formulations.
Contact Lens Comfort Study (2016)
This 90-day multicenter randomized trial compared:
· CMC-HA combination drops (0.5% CMC + 0.1% HA)
· CMC-only drops (0.5% CMC)
In 365 contact lens wearers, the combination group showed:
· 36% greater reduction in end-of-day dryness (p = 0.006)
· 40% greater reduction in burning/stinging (p = 0.02 at throughout day; p < 0.001 at end of day)
· Significant improvement in lid wiper epitheliopathy (p = 0.009)
· Greater reduction in conjunctival staining (p = 0.08)
The conclusion: Adding hyaluronic acid to a standard CMC rewetting drop "improves clinical performance."
A 2025 study published in MDPI's Pharmaceutics journal evaluated a triple-action formulation combining HA, ectoine, and CMC. Findings demonstrated:
· Enhanced mucoadhesion compared to binary combinations
· Sustained ectoine release over 24 hours
· Superior anti-inflammatory effects in allergic conjunctivitis models
· Improved tear film stability through synergistic polymer action
This research supports the emerging consensus: strategic combinations outperform single-polymer approaches.
Both polymers demonstrate concentration-dependent efficacy:
Sodium Hyaluronate Concentrations
Concentration | Characteristics | Best Use |
0.05-0.1% | Light, refreshing | Mild symptoms, daytime use |
0.1-0.2% | Balanced viscosity | Moderate dry eye, general use |
0.2-0.3% | High viscosity | Severe dry eye, overnight use |
Carboxymethylcellulose Concentrations
Concentration | Characteristics | Best Use |
0.25-0.5% | Standard viscosity | Mild-moderate symptoms |
0.5-1.0% | Enhanced lubrication | Moderate-severe symptoms, post-surgical |
Patent literature reveals optimized combinations have been developed:
Effective Combinations:
· 0.5% CMC + 0.1% HA: Balanced for general dry eye use
· 0.5% CMC + 0.15% HA: Enhanced for moderate-severe symptoms
· Triple combinations with osmoprotectants (erythritol, trehalose, L-carnitine)
Why These Ratios Work:
· CMC provides immediate surface coating and binding
· HA delivers sustained hydration and viscoelastic lubrication
· The combination addresses both immediate symptom relief and prolonged protection
· Additional osmoprotectants counteract hyperosmolarity, a key driver of dry eye pathology
For pharmaceutical and supplement manufacturers, both polymers offer advantages:
Sodium Hyaluronate:
· Requires careful molecular weight control
· Fermentation-derived sources offer consistent quality
· Higher cost but premium positioning potential
Carboxymethylcellulose:
· Well-established manufacturing processes
· Cost-effective for standard formulations
· Excellent stability and shelf life
Combination Products:
· Require sophisticated formulation development
· Regulatory considerations for multiple active ingredients
· Higher development investment but stronger market differentiation
Sodium hyaluronate is particularly appropriate when:
Rapid Symptom Relief Needed
Studies suggest faster onset of action, making it suitable for patients seeking quick relief from acute dry eye symptoms.
Post-Surgical Recovery
Sodium hyaluronate's wound healing promotion through CD44 signaling supports corneal recovery after procedures like cataract surgery or LASIK.
Moderate to Severe Dry Eye
Higher viscosity formulations provide extended protection for patients with significant symptoms.
Contact Lens Wearers
The lubricating and protective properties reduce friction between lenses and corneal tissue.
CMC is particularly appropriate when:
Extended Surface Protection Required
The direct epithelial binding mechanism provides longer-lasting surface protection compared to coating-only approaches.
Budget-Conscious Patients
CMC formulations typically cost less while maintaining clinical efficacy.
Mild to Moderate Symptoms
Standard concentrations effectively manage symptoms without the premium pricing of HA derivatives.
Formulation Flexibility Needed
CMC's stability and compatibility with various excipients simplify manufacturing and allow diverse product formats.
For patients not achieving adequate relief from single-polymer products, combination formulations offer:
· Immediate relief from CMC's surface binding and coating
· Sustained hydration from sodium hyaluronate's water retention
· Enhanced wound healing from both polymers' epithelial effects
· Better overall symptom control demonstrated in clinical trials
The evidence increasingly supports moving beyond "either/or" thinking about sodium hyaluronate and carboxymethylcellulose. The most effective artificial tears of tomorrow will likely employ strategic combinations tailored to specific patient needs.
Emerging Trends:
Triple-Action Formulations
Combinations of HA + CMC + osmoprotectants address multiple dry eye pathways simultaneously—hydration, protection, and osmotic balance.
Condition-Specific Products
Products tailored for specific indications:
· Post-surgical formulations emphasizing wound healing
· Contact lens rewetters prioritizing friction reduction
· Allergic dry eye combinations with anti-inflammatory components
Novel Delivery Systems
Advances in nanotechnology and sustained-release formulations may further enhance the benefits of combined polymer approaches.
For manufacturers developing next-generation artificial tear products, Shandong Runxin Biotechnology offers pharmaceutical-grade sodium hyaluronate原料 optimized for ophthalmic applications.
Sodium Hyaluronate Grades
· Ophthalmic Grade SH: Molecular weight 500-1,500 kDa, optimized for ocular surface retention
· High-Viscosity SH: 1,500-2,200 kDa for enhanced lubrication in severe dry eye
· Low-Molecular-Weight SH: 50-400 kDa for improved corneal penetration when needed
Quality Assurance
Every batch undergoes rigorous testing:
· Molecular weight verification via GPC-MALS
· Endotoxin levels <0.5 EU/mL (USP/EP compliant)
· Sterility testing per pharmacopeial requirements
· Heavy metal and protein residual testing
· Complete certificate of analysis with each shipment
Beyond supplying原料, Runxin supports your formulation development:
· Rheological optimization for target viscosity profiles
· Compatibility testing with CMC and other excipients
· Stability study support for combination products
· Regulatory documentation (DMF, CEP, technical files)
With 28+ years of hyaluronic acid expertise and 300+ proprietary technologies, Runxin helps you develop differentiated artificial tear products that leverage the complementary strengths of sodium hyaluronate and carboxymethylcellulose.
The comparison between sodium hyaluronate and carboxymethylcellulose ultimately reveals not competition but complementarity. Each polymer brings unique mechanisms to ocular surface protection:
· Sodium hyaluronate excels in rapid hydration, viscoelastic lubrication, and CD44-mediated wound healing
· Carboxymethylcellulose provides superior epithelial binding, extended surface protection, and cost-effective symptom relief
Clinical evidence suggests the greatest benefits emerge from strategic combination—leveraging each polymer's strengths while mitigating individual limitations. The 90-day contact lens study demonstrating CMC-HA superiority over CMC alone, and the emerging triple-action formulations combining HA, CMC, and osmoprotectants, point toward a future where artificial tears are precision-engineered combinations rather than single-ingredient solutions.
For healthcare professionals, this means personalized recommendations based on patient symptoms, severity, and preferences. For manufacturers, the opportunity lies in developing differentiated combination products that address the multifactorial nature of dry eye disease more comprehensively than single-polymer approaches ever could.
The next time you compare artificial tear options, remember: the real story isn't sodium hyaluronate versus carboxymethylcellulose—it's how understanding their complementary mechanisms enables better outcomes for the patients and customers you serve.
Keywords: sodium hyaluronate eye drops, carboxymethylcellulose eye drops, CMC vs SH, artificial tears comparison, dry eye treatment polymer, CMC HA combination
Meta Description: Sodium hyaluronate vs carboxymethylcellulose eye drops: which works better? Discover the complementary mechanisms of SH and CMC for effective dry eye treatment.
